'This study really opens up the possibility that people on the more severe end of the #psychiatric spectrum could benefit more than we thought.”

Bessel van der Kolk, MD, discusses the long-term outlook on #MDMA assisted therapy for #PTSD .

Watch: hcplive.com/view/bessel-va…

A similar proportion of patients sustained baseline clinical status in the reference #adalimumab group and #biosimilar #SB5 group.

Read more:
hcplive.com/view/patients-…

Breaking this morning: the #FDA has extended the target action date of Sanofi & Regeneron's priority review application for dupilumab (Dupixent) as an add-on #COPD treatment.

Read more here: hcplive.com/view/fda-exten…

Dr. Antonio Anzueto invites you to a COPD roundtable discussion. Join us on June 5 at 6:30 PM in San Antonio, TX. Register Now: bit.ly/3JFQD51

ICYMI: For World Digestive Health Day, we launched a feature examining the growth of intestinal ultrasound in IBD care in the US and how it aligns with STRIDE-II guidance.

hcplive.com/view/redefinin…

#IBD #Gastroenterology

🚨Mark your calendars!🚨
On June 04 at 6 PM EST, we will be hosting a live-stream on YouTube with Franklin King MD a board-certified psychiatrist, immediately following the FDA's PDAC on Lykos Therapeutics MDMA capsules in the treatment of #PTSD .
youtube.com/live/6tjnFxnkq…
#Psychiatry

Check out anything you may have missed from #ERA24 thus far by heading over to our #Nephrology resource center on HCPLive:
hcplive.com/clinical/nephr…

Watch now to explore a treatment option for neovascular age-related macular degeneration and diabetic macular edema. bit.ly/3Iqi6XL

Please see additional Important Safety Information in the full VABYSMO Prescribing Information: bit.ly/487nwlZ

#ICYMI : Check out an exclusive interview with ARVO President Srinivas R. Sadda, MD Doheny Eye Institute discussing his goals as the organization's leader and what's to come in #ophthalmology .

Link here 🔒
hcplive.com/view/arvo-pres…

At week 54, the clinical remission rate among patients receiving originator #infliximab was 92.5% compared with 100% in the biosimilar CT-P13 group.

Learn more:
hcplive.com/view/remission…
#Biosimilars

ICYMI: The FDA approved eculizumab-aeeb (Bkemv) as an interchangeable biosimilar to eculizumab (Soliris) for treating PNH and aHUS, marking the agency’s 53rd biosimilar approval.

hcplive.com/view/fda-appro…

#Biosimilars

A recent study from Liz Sapey of Inflammation and Ageing is calling attention to an increased risk of #CVD measured by arterial stiffness when adjusted for age and #smoking history in patients with #AATD , but only when screened with certain tests.

Learn more:
hcplive.com/view/tradition…

PACMAN-AMI: Alirocumab added to high-intensity statin therapy did not further improve endothelial function in patients with acute myocardial infarction.

Read here 👇
hcplive.com/view/pacman-am…

#Cholesterol

Among included #RheumatoidArthritis studies, 83.3% showed significantly better clinical outcomes in patients managed with a T2T strategy compared with usual care.

Learn more:
hcplive.com/view/treat-to-…

A new study found poor #sleep quality is independently associated with #pain , and 16% of patients with rheumatoid #arthritis and 22% of patients with PsA had sleeping issues.

hcplive.com/view/poor-slee…

Dr. Nicola Hanania invites you to a COPD roundtable discussion. Join us on May 30 at 6:30 PM in Dallas, TX. Register Now: bit.ly/3xYtXKt

Discover how different manifestations of plaque psoriasis influence treatment choice, and discuss when it may be appropriate for certain patients to transition to systemics. Watch Now bit.ly/40j11a6

Hear from Dr Neuen as he joins #DontMissABeat to discuss the FLOW trial from #ERA24 and what it means for the future of semaglutide and kidney disease management.

hcplive.com/view/dont-miss…

#ChronicKidneyDisease

In honor of World #Digestive Health Day, this feature spotlights the recent emergence of intestinal ultrasound in #IBD management in the United States and its potential to aid the implementation of treat-to-target strategies.

#WDHD2024 #IUS

hcplive.com/view/redefinin…